Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
197 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
UNC scientists describe protein that protects against colon cancer
by Mary Ruth published Apr 13, 2012 last modified Apr 20, 2012 11:32 AM — filed under: , ,
Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.
Located in News / 2012 News
Study recommends national standards for tobacco use treatment
by Mary Ruth published Apr 16, 2012 last modified Apr 16, 2012 12:00 PM — filed under: , ,
National Cancer Institute-designated cancer centers should lead the way
Located in News / 2012 News
Three-dimensional RNA modeling opens scientific doors
by Mary Ruth published Apr 16, 2012 last modified Apr 17, 2012 10:05 AM — filed under: ,
Chapel Hill, NC – In a paper published today in the journal Nature Methods, a team from the University of North Carolina at Chapel Hill demonstrates a simple, cost-effective technique for three-dimensional RNA structure prediction that will help scientists understand the structures, and ultimately the functions, of the RNA molecules that dictate almost every aspect of human cell behavior. When cell behavior goes wrong, diseases – including cancer and metabolic disorders – can be the result.
Located in News / 2012 News
UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
by Mary Ruth published May 02, 2012 last modified May 03, 2012 12:02 PM — filed under: , ,
Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach.
Located in News / 2012 News
DeSimone elected into National Academy of Sciences
by Mary Ruth published May 03, 2012 last modified May 03, 2012 10:09 AM — filed under: ,
Dr. Joseph DeSimone, PhD, Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, has been elected into the National Academy of Sciences, one of the highest honors that a U.S. scientist or engineer can receive.
Located in News / 2012 News
Review study makes recommendations to enhance Cancer Comparative Effectiveness Research
by Mary Ruth published May 03, 2012 — filed under: ,
Which treatment for prostate cancer is most effective? Will a specific combination of cancer drugs increase patient survival for colon cancer? As the pace of scientific discovery continues to accelerate, patients and their providers face more choices and decisions about how to address their health care needs, and information that can help inform their decisions is often hard to find.
Located in News / 2012 News
Der receives grant funding for pancreatic cancer research
by Mary Ruth published May 07, 2012 last modified May 08, 2012 09:56 AM — filed under: , ,
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.
Located in News / 2012 News
Postdoctoral fellow receives DOD Visionary Fellowship Award
by Mary Ruth published May 08, 2012 last modified May 08, 2012 01:05 PM — filed under: , ,
Idoia Garcia, PhD, a postdoctoral fellow in the lab of Timothy Gershon, MD, PhD, has been awarded a Department of Defense Visionary Postdoctoral Fellowship Award. The peer-reviewed award is intended to support exceptionally talented recent medical or other doctoral graduates in their pursuit of cutting-edge, innovative, high-risk/high-impact cancer research during their postdoctoral fellowship.
Located in News / 2012 News
Stem cells poised to self-destruct for the good of the embryo
by Mary Ruth published May 03, 2012 last modified May 09, 2012 09:55 AM — filed under: ,
Embryonic stem cells are primed to kill themselves if damage to their DNA makes them a threat to the developing embryo. UNC researchers reveal how they do it.
Located in News / 2012 News
Thriving on science: in depth with Jason Lieb
by Mary Ruth published May 09, 2012 last modified May 11, 2012 10:21 AM — filed under: ,
Jason Lieb likes to mix it up. A triathlete, he enjoys running, swimming and cycling. In his lab, he works in several model systems: yeast, round worms (C. elegans), fruit flies (Drosophila melanogaster) and human cell lines.
Located in News / 2012 News